BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 31238605)

  • 41. Impact of hepatitis B vaccination among children in Guangdong Province, China.
    Xiao J; Zhang J; Wu C; Shao X; Peng G; Peng Z; Ma W; Zhang Y; Zheng H
    Int J Infect Dis; 2012 Sep; 16(9):e692-6. PubMed ID: 22795176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A serological and molecular survey of hepatitis B in children 15 years after inception of the national hepatitis B vaccination program in eastern China.
    Dong Y; Liu SL; Zhai XJ; Zhu FC; Pan H; Yu JX; Chen YZ; Xie YR; Zhang XY; Zhang HM; Li LJ; Wang H; Ruan B
    J Med Virol; 2009 Sep; 81(9):1517-24. PubMed ID: 19626618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft.
    Wang SH; Loh PY; Lin TL; Lin LM; Li WF; Lin YH; Lin CC; Chen CL
    Liver Transpl; 2017 Oct; 23(10):1266-1272. PubMed ID: 28691231
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets.
    Spearman CW; Afihene M; Ally R; Apica B; Awuku Y; Cunha L; Dusheiko G; Gogela N; Kassianides C; Kew M; Lam P; Lesi O; Lohouès-Kouacou MJ; Mbaye PS; Musabeyezu E; Musau B; Ojo O; Rwegasha J; Scholz B; Shewaye AB; Tzeuton C; Sonderup MW;
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):900-909. PubMed ID: 29132759
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemiological study of hepatitis B and hepatitis C infections in Northeastern China and the beneficial effect of the vaccination strategy for hepatitis B: a cross-sectional study.
    Wang S; Tao Y; Tao Y; Jiang J; Yan L; Wang C; Ding Y; Yu J; Zhao D; Chi X; Wang X; Wu R; Gao X; Shi Y; Guan Y; Li Y; Xing Y; Sun H; Ta C; Wang C; Niu J; Meng J; Xu H
    BMC Public Health; 2018 Sep; 18(1):1088. PubMed ID: 30176842
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Key outcomes and addressing remaining challenges--perspectives from a final evaluation of the China GAVI project.
    Yang W; Liang X; Cui F; Li L; Hadler SC; Hutin YJ; Kane M; Wang Y
    Vaccine; 2013 Dec; 31 Suppl 9():J73-8. PubMed ID: 24331024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Seroepidemiology of hepatitis B virus infection and impact of vaccination.
    Huang P; Zhu LG; Zhu YF; Yue M; Su J; Zhu FC; Yang HT; Zhang Y; Shen HB; Yu RB; Zhai XJ; Peng ZH
    World J Gastroenterol; 2015 Jul; 21(25):7842-50. PubMed ID: 26167084
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An epidemiological serosurvey of hepatitis B virus shows evidence of declining prevalence due to hepatitis B vaccination in central China.
    Yonghao G; Jin X; Jun L; Pumei D; Ying Y; Xiuhong F; Yanyang Z; Wanshen G
    Int J Infect Dis; 2015 Nov; 40():75-80. PubMed ID: 26456567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis B control among children in the Eastern Mediterranean Region of the World Health Organization.
    Allison RD; Teleb N; Al Awaidy S; Ashmony H; Alexander JP; Patel MK
    Vaccine; 2016 May; 34(21):2403-2409. PubMed ID: 27043863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis B-related knowledge and vaccination in association with discrimination against Hepatitis B in rural China.
    Yu L; Wang J; Zhu D; Leng A; Wangen KR
    Hum Vaccin Immunother; 2016; 12(1):70-6. PubMed ID: 26211570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 20 μg hepatitis B vaccination reduced the risk of low responsiveness in infants with HLA-II risk genotype of HBsAg positive mothers.
    Cao M; Wu Y; Wen S; Pan Y; Wang C; Zhang X; Kong F; Lu Y; Wang C; Niu J; Li J; Jiang J
    Infect Genet Evol; 2018 Sep; 63():243-248. PubMed ID: 29883771
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning.
    Nayagam S; Chan P; Zhao K; Sicuri E; Wang X; Jia J; Wei L; Walsh N; Rodewald LE; Zhang G; Ailing W; Zhang L; Chang JH; Hou W; Qiu Y; Sui B; Xiao Y; Zhuang H; Thursz MR; Scano F; Low-Beer D; Schwartländer B; Wang Y; Hallett TB
    Clin Infect Dis; 2021 Mar; 72(5):743-752. PubMed ID: 32255486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The maternal viral threshold for antiviral prophylaxis of perinatal hepatitis B virus transmission in settings with limited resources: A large prospective cohort study in China.
    Lu Y; Zhu FC; Liu JX; Zhai XJ; Chang ZJ; Yan L; Wei KP; Zhang X; Zhuang H; Li J
    Vaccine; 2017 Dec; 35(48 Pt B):6627-6633. PubMed ID: 29079104
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vaccination against Hepatitis B: A Scoping Review.
    Mohanty P; Jena P; Patnaik L
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3453-3459. PubMed ID: 33369439
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation.
    Burnett RJ; François G; Kew MC; Leroux-Roels G; Meheus A; Hoosen AA; Mphahlele MJ
    Liver Int; 2005 Apr; 25(2):201-13. PubMed ID: 15780040
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Control of hepatitis B in China: prevention and treatment.
    Wang Y; Jia J
    Expert Rev Anti Infect Ther; 2011 Jan; 9(1):21-5. PubMed ID: 21171874
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis B virus elimination status and strategies in circumpolar countries, 2020.
    Haering C; McMahon B; Harris A; Weis N; Lundberg Ederth J; Axelsson M; Olafsson S; Osiowy C; Tomas K; Bollerup S; Liitsola K; Archibald C; Blystad H; Bruce M; Nolen L
    Int J Circumpolar Health; 2021 Dec; 80(1):1986975. PubMed ID: 34668463
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis B Vaccine in national immunization schedule: a preventive step in India.
    Verma R; Khanna P; Prinja S; Rajput M; Chawla S; Bairwa M
    Hum Vaccin; 2011 Dec; 7(12):1387-8. PubMed ID: 22134433
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Perinatal hepatitis B prevention program in Shandong Province, China. Evaluation and progress.
    Zhang L; Ko S; Lv J; Ji F; Yan B; Xu F; Xu A
    Hum Vaccin Immunother; 2014; 10(9):2755-60. PubMed ID: 25483482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.